Are patients with RA at increased risk of malignancy?

被引：1
|
作者：
Hyrich, Kimme L. [1 ,2 ]
机构：
[1] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England
[2] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2008年 / 4卷 / 12期
关键词：
anti-TNF; cancer; meta-analysis; rheumatoid arthritis;
D O I：
10.1038/ncprheum0924
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, Smitten and colleagues conducted a meta-analysis of the risk of cancer in patients with rheumatoid arthritis ( RA) compared with that in the general population. The authors found no important differences in the overall risk of cancer in patients with RA. However, the risk of lymphoma and lung cancer seemed to be increased, whereas colorectal cancer and breast cancer risk was decreased. With recent changes in the therapeutic approach to RA, concern has been raised about the role of anti-tumor necrosis factor therapies in inducing or increasing the risk of lymphoma and other malignancies. However, it is important to consider the baseline risk of these malignancies in patients with RA when placing the risk of new therapies into context.
引用
收藏
页码：632 / 633
页数：2
相关论文
共 50 条
  • [1] Are patients with RA at increased risk of malignancy?
    Kimme L Hyrich
    Nature Clinical Practice Rheumatology, 2008, 4 : 632 - 633
  • [2] MALIGNANCY RISK IS INCREASED IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Kasifoglu, T.
    Bilge, N. S. Yasar
    Yildiz, F.
    Ozen, G.
    Pehlivan, Y.
    Yilmaz, N.
    Tarhan, F.
    Yilmaz, S.
    Kucuk, A.
    Emmungil, H.
    Koca, S.
    Cinar, M.
    Korkmaz, C.
    Direskeneli, H.
    Arslantas, D.
    Erken, E.
    Can, G.
    Ozmen, M.
    Gonullu, E.
    Kisacik, B.
    Aksu, K.
    Karadag, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 655 - 655
  • [3] Are patients with primary glomerular disease at increased risk of malignancy?
    Han, Jialin
    Zhao, Yinshan
    Canney, Mark
    Atiquzzaman, Mohammad
    Keown, Paul
    Levin, Adeera
    Barbour, Sean
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (06) : 910 - 919
  • [4] Increased risk of malignancy in patients with systemic lupus erythematosus
    Ramsey-Goldman, R
    Mattai, SA
    Schilling, E
    Chiu, YL
    Alo, CJ
    Howe, HL
    Manzi, S
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (05) : 217 - 222
  • [5] Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
    Marzecka, Milena
    Niemczyk, Anna
    Rudnicka, Lidia
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 63 (02) : 289 - 296
  • [6] Increased Risk of Malignancy in Elderly Patients with Inflammatory Myositis
    Kim, Hyoungyoung
    Sung, Yoon-Kyoung
    Choi, Seongmi
    Kim, Jinwook
    Jung, Sun-Young
    Jang, Eun Jin
    Yoo, Dae-Hyun
    Cho, Soo-Kyung
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
    Milena Marzęcka
    Anna Niemczyk
    Lidia Rudnicka
    Clinical Reviews in Allergy & Immunology, 2022, 63 : 289 - 296
  • [8] Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?
    O'Dwyer, Elisabeth
    Halpenny, Darragh F.
    Ginsberg, Michelle S.
    EUROPEAN RADIOLOGY, 2021, 31 (01) : 458 - 467
  • [9] Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?
    Elisabeth O’Dwyer
    Darragh F. Halpenny
    Michelle S. Ginsberg
    European Radiology, 2021, 31 : 458 - 467
  • [10] No increased risk of cancer or death with cyclosporin in RA patients
    Reactions Weekly, 1998, 731 (1) : 5 - 5
12345